This site was updated on
August 25, 2010.
 |
 |
 |
 |
What’s new?
Alberta, New Brunswick, Nova Scotia and NIHB (Non-Insured Health Benefits Program) lead the way with the listing of SIMPONI™ for three rheumatic conditions
For more information, click here.
Merck Reports that Two Pivotal Phase III Registration Studies for Boceprevir Have Been Completed and Meet the Primary Endpoints
For more information, click here.
Merck Details Plans to Restructure Merck Frosst as Part of a Global Initiative to Integrate Worldwide Operations, Following the Merger of Merck and Schering-Plough
For more information, click here.
Merck Announces Launch of Pioneering Collaborative Cancer Trials Network at 2010 American Society of Clinical Oncology Meeting
For more information, click here.
Merck and Cardiome Announce Phase III Study Results Comparing Investigational Compound Vernakalant Intravenous to Amiodarone Injection in Conversion of Atrial Fibrillation to Normal Sinus Rhythm
For more information, click here.
Merck Highlights Robust Late-Stage Pipeline, Global Business Strategy and Progress of Integration
For more information, click here.
Merck Positioned to Drive Growth Through Innovative Portfolio, Pipeline and Strategy for Growth in Emerging Markets
For more information, click here.
Recent Features
New 3D anatomical models which will allow you to explore all corners of the human body. You can move these anatomical models and raise the flesh to have a full 3D effect simply by a twist of the mouse!
Click here to find out!
If you never gave chickenpox a second thought… Think again.
There is something you can do.
Help protect your child against chickenpox.
Click here to find out!
A New Look at Asthma
Education may be your key to taking control of your asthma. Visit our new asthma site to learn more about asthma and the treatments available.
